CALA: Message Board for Calithera Biosciences, Inc. - InvestorVillage

Calithera Biosciences, Inc.

  CALA website

  • Get 3 months of ad-free premium service for every $25 you contribute
    to support critical site improvement efforts.
    With no recurring subscription
    to worry about, this an ideal way to test drive our premium service.

    Premium features, such as multi-message viewing (i.e., being able to open
    up to 100 messages with a single click) can save you lots of time
    over the course of a busy day, to say nothing of an entire year!
    Watch this 2-min video to see why premium is right for you.

    *Offer expires at midnight


CALA   /  Message Board



Rec'd By
Authored By
Minimum Recs
Previous 2500 Messages Top of Message List
Go to Msg #  
2705 CANTATA GN JoeFlow 1 10/3/2019 3:12:10 PM
2704 was P-value, now CALA compare to early EXEL GN JoeFlow 3 10/1/2019 11:10:57 PM
2703 Re: CALA management is a fiasco GN rebear 1 10/1/2019 3:07:01 PM
2702 CALA management is a fiasco GN logansdad 3 10/1/2019 2:44:49 PM
2701 CALA GN bioinvestdude 0 10/1/2019 2:44:41 PM
2700 Re: EXEL and ARRY GN bioinvestdude 0 9/30/2019 11:42:49 AM
2699 CALA- Arginase GN Mongo19 0 9/29/2019 11:25:45 AM
2698 Re: EXEL and ARRY GN wilderguide 2 9/28/2019 6:22:24 PM
2697 EXEL and ARRY GN bioinvestdude 0 9/28/2019 1:31:50 PM
2696 Data From Randomized Phase 2 ENTRATA Study Demonstrate Telaglenastat with Everolimus Improves Progression-Free Survival in Renal Cell Carcinoma GN Pacific 3 9/28/2019 2:52:40 AM
Previous 2500 Messages Top of Message List
Go to Msg #  

About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 All rights reserved. User Agreement
Financial Market Data provided by